Nurse prepares a dose of the COVID-19 vaccine during home visits near Wirksworth, Derbyshire Britain. File/Reuters
Britain’s medical regulator on Thursday said it would fast-track vaccines for coronavirus variants, adding that the makers of already-authorised shots would not need new lengthy clinical trials to prove their adapted vaccines will work.
There is concern that some variants, such as those first found in South Africa and Brazil, may reduce the efficacy of the first generation of COVID-19 vaccines, and manufacturers are looking to adapt their shots.
The accelerated process is based on that used for seasonal flu vaccines each year, the Medicines & Healthcare products Regulatory Agency (MHRA) said, and would be based on robust evidence that the shots create an immune response, rather than full clinical trials.
“Our priority is to get effective vaccines to the public in as short a time as possible, without compromising on safety,” said Christian Schneider, chief scientific officer at the MHRA.
“Should any modifications to authorised COVID-19 vaccines be necessary, this regulatory approach should help to do just that.”
The MHRA said that researchers would be able to measure protection by looking at antibodies in the blood after vaccination.
As well as data on immune response, vaccine makers will need evidence the vaccine is safe, and data from original clinical trials and real-world evidence from vaccine rollout could also be used.
The MHRA said it had developed the advice in conjunction with regulators in Australia, Canada, Singapore and Switzerland.
AstraZeneca, Pfizer and Moderna, the makers of the three vaccines the MHRA has approved for use so far, have all said they are aiming to modify their shots to cope with variants this year.
Britain, which is rolling out shots made by AstraZeneca and Pfizer, has given a first shot of a vaccine to over 20 million people. Despite regulatory approval, Moderna’s vaccine is yet to be rolled out in the country.
Each casualty of the virus lost an average of 10 years of life when they died, according to an analysis by respected think tank the Health Foundation.
New cases totalled 6,040, a slight rise on Friday's 5,947, government data showed, while the number of people who had received the first dose of a COVID-19 vaccine rose to 21,796,278.
The latest EU-UK row is about an AstraZeneca plant in the Netherlands, which Prime Minister Boris Johnson's government claims as part of the British vaccine supply chain.
Taylor-Anna Kobinger, a resident of the province of Quebec, published an advertisement on Facebook for the sale of her car, which is an Audi A4.
Israel and Sudan agreed to press on with efforts to normalise relations during a visit by Israeli foreign minister Eli Cohen to Khartoum on Thursday, Sudan's foreign ministry said.
The fees for extending the validity of a visa are Dhs200, including Dhs100 for the smart services, Dhs50 for the application form and Dhs50 for the Authority and the electronic services offered to customers.
The one-wheel drive vehicle is equipped with dual-circuit hydraulic braking system. The weight of the extremely streamlined solar vehicle is just over 160 kilogrammes. The Megalux has plastic body and sandwich structure made of carbon fibre.